| Description | CV-1808 is a coronary vasodilator, antihypertensive, and antipsychotic following systemic administration in vivo. CV-1808 is an adenosine A2 receptor agonist. |
| Synonyms | CV 1808, CV-1808 |
| molecular weight | 358.35 |
| Molecular formula | C16H18N6O4 |
| CAS | 53296-10-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: Soluble |
| References | 1. Cornfield LJ, Hu S, Hurt SD, Sills MA. [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain. J Pharmacol Exp Ther. 1992 Nov;263(2):552-61. PubMed PMID: 1331404. 2. Hardart GE, Sullivan GW, Carper HT, Mandell GL. Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function. Infect Immun. 1991 Mar;59(3):885-9. PubMed PMID: 1847698; PubMed Central PMCID: PMC258343. 3. Tanabe M, Terashita Z, Nishikawa K, Hirata M. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):442-8. PubMed PMID: 6202970. 4. Taylor DA, Williams M. Interaction of 2-phenylaminoadenosine (CV 1808) with adenosine systems in rat tissues. Eur J Pharmacol. 1982 Dec 3;85(3-4):335-8. PubMed PMID: 6295788. |